ES2149969T3 - Composicion antitusiva que contiene un antitusivo y benzidamina. - Google Patents

Composicion antitusiva que contiene un antitusivo y benzidamina.

Info

Publication number
ES2149969T3
ES2149969T3 ES95909772T ES95909772T ES2149969T3 ES 2149969 T3 ES2149969 T3 ES 2149969T3 ES 95909772 T ES95909772 T ES 95909772T ES 95909772 T ES95909772 T ES 95909772T ES 2149969 T3 ES2149969 T3 ES 2149969T3
Authority
ES
Spain
Prior art keywords
antitusive
benzidamine
composition containing
oral
acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909772T
Other languages
English (en)
Inventor
Angeli Depalmo Galli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2149969T3 publication Critical patent/ES2149969T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA ANTITUSIVA ORAL QUE PERMITE UN CONTACTO SIGNIFICATIVO DE SUS COMPONENTES CON LAS MEMBRANAS MUCOSAS DE LA CAVIDAD BUCAL Y ESTA COMPUESTO POR UN ANTITUSIVO DE ACCION CENTRAL O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES Y BENZIDAMINA O UNA DE SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE.
ES95909772T 1994-03-01 1995-02-22 Composicion antitusiva que contiene un antitusivo y benzidamina. Expired - Lifetime ES2149969T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940362A IT1274026B (it) 1994-03-01 1994-03-01 Composizione antitosse

Publications (1)

Publication Number Publication Date
ES2149969T3 true ES2149969T3 (es) 2000-11-16

Family

ID=11368015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909772T Expired - Lifetime ES2149969T3 (es) 1994-03-01 1995-02-22 Composicion antitusiva que contiene un antitusivo y benzidamina.

Country Status (27)

Country Link
US (1) US5932589A (es)
EP (1) EP0748222B1 (es)
JP (1) JP3348858B2 (es)
KR (1) KR970701047A (es)
CN (1) CN1088358C (es)
AT (1) ATE195074T1 (es)
AU (1) AU681257B2 (es)
BR (1) BR9506956A (es)
CA (1) CA2184594C (es)
CZ (1) CZ284798B6 (es)
DE (1) DE69518229T2 (es)
DK (1) DK0748222T3 (es)
ES (1) ES2149969T3 (es)
FI (1) FI963394A7 (es)
GR (1) GR3034665T3 (es)
HU (1) HUT75937A (es)
IT (1) IT1274026B (es)
NO (1) NO309965B1 (es)
NZ (1) NZ281230A (es)
PL (1) PL178608B1 (es)
PT (1) PT748222E (es)
RO (1) RO117147B1 (es)
RU (1) RU2143901C1 (es)
SK (1) SK282567B6 (es)
UA (1) UA37278C2 (es)
WO (1) WO1995023602A1 (es)
ZA (1) ZA951588B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124282A (en) * 1997-05-22 2000-09-26 Sellers; Edward M. Drug formulations
EP1041987B1 (en) * 1997-12-22 2006-04-19 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone
JP2003509455A (ja) * 1999-04-06 2003-03-11 ダブリューエム リグリー ジュニア カンパニー 医薬チューインガム製剤
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
JP5144277B2 (ja) * 2005-01-14 2013-02-13 カムルス エービー 局所用生体付着性製剤
US9757461B2 (en) * 2005-01-14 2017-09-12 Camurus Ab GnRH analogue formulations
CN101219140B (zh) * 2007-12-24 2011-06-01 重庆市莱美药物技术有限公司 盐酸苄达明可溶片及其制备方法
SG176686A1 (en) 2009-07-08 2012-01-30 Acraf USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
CN105188677A (zh) * 2013-03-13 2015-12-23 特瑞斯制药股份有限公司 苯佐那酯调释固体片剂和胶囊剂
CN107873024A (zh) * 2015-02-09 2018-04-03 塞尔利克斯生物私人有限公司 用于治疗粘膜炎的组合物和方法
US11214544B2 (en) 2017-04-14 2022-01-04 Kempharm, Inc. Dextrorphan prodrugs and processes for making and using them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (es) * 1963-08-09
CA2129676C (en) * 1990-10-31 1997-09-30 Ronald Lee Smith Dextromethorphan antitussive compositions
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions

Also Published As

Publication number Publication date
DE69518229T2 (de) 2001-03-08
EP0748222A1 (en) 1996-12-18
FI963394L (fi) 1996-08-30
CN1143909A (zh) 1997-02-26
AU1811695A (en) 1995-09-18
AU681257B2 (en) 1997-08-21
NO963634L (no) 1996-08-30
JP3348858B2 (ja) 2002-11-20
WO1995023602A1 (en) 1995-09-08
CZ284798B6 (cs) 1999-03-17
DE69518229D1 (de) 2000-09-07
CA2184594C (en) 2002-09-17
BR9506956A (pt) 1997-09-16
NO309965B1 (no) 2001-04-30
JPH09509670A (ja) 1997-09-30
US5932589A (en) 1999-08-03
KR970701047A (ko) 1997-03-17
PL178608B1 (pl) 2000-05-31
ITMI940362A1 (it) 1995-09-01
ITMI940362A0 (it) 1994-03-01
SK108596A3 (en) 1997-04-09
EP0748222B1 (en) 2000-08-02
HU9602390D0 (en) 1996-10-28
FI963394A0 (fi) 1996-08-30
PT748222E (pt) 2001-01-31
RO117147B1 (ro) 2001-11-30
HUT75937A (en) 1997-05-28
ZA951588B (en) 1995-12-08
UA37278C2 (uk) 2001-05-15
SK282567B6 (sk) 2002-10-08
PL316079A1 (en) 1996-12-23
DK0748222T3 (da) 2000-12-18
ATE195074T1 (de) 2000-08-15
MX9603747A (es) 1997-12-31
CN1088358C (zh) 2002-07-31
CZ253296A3 (en) 1997-01-15
NZ281230A (en) 1998-04-27
FI963394A7 (fi) 1996-08-30
IT1274026B (it) 1997-07-14
NO963634D0 (no) 1996-08-30
RU2143901C1 (ru) 2000-01-10
CA2184594A1 (en) 1995-09-08
GR3034665T3 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
ES2149969T3 (es) Composicion antitusiva que contiene un antitusivo y benzidamina.
ES2154288T3 (es) Composicion farmaceutica bioadhesiva para la liberacion controlada de principios activos.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
AR002932A1 (es) Solucion acuosa de interferon
ES2171971T3 (es) Producto limpiador y de tratamiento con almidon.
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
ES2174091T3 (es) Dispositivo para la alineacion paralela de macromoleculas y utilizacion del mismo.
DK0776229T3 (da) Brusedyse
TR28474A (tr) Sodyum alkol etoksi gliseril sülfonat iceren, vücut temizleyici yumusak bilesikler.
BR8705187A (pt) Dispositivo higienizador da cavidade bucal
DE3865100D1 (de) Elektrodenlose niederdruckentladungslampe.
DE3865553D1 (de) Elektrodenlose niederdruckentladungslampe.
ES2166813T3 (es) Composicion limpiadora para dentaduras.
NO20033161L (no) Linsepleieprodukt inneholdende dexpantenol
ES2151517T3 (es) Efectos de filamentos de actina sobre la estructura y lisis de coagulos de fibrina.
PT1131408E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
DE69608959D1 (de) Chlamydia impfstoffen
ES2109632T3 (es) Composicion de dentifrico anhidro.
PA7801701A1 (es) Compuestos ariltios
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
FI884351A7 (fi) Muotojäljennösten desifiointi.
IT1318447B1 (it) Formulazioni per la rimozione della placca dentale e del tartaro.
ES2051183B1 (es) Composicion explosiva
IT8621291A1 (it) Composizioni per la disinfezione di lenti a contatto
IT1272995B (it) Procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 748222

Country of ref document: ES